StockWatch: IPO Market Shows Sign of Life with Avalyn Filing

The initial public offering (IPO) market showed signs of life for the first time in more than a month as Boston-based Avalyn Pharma filed a registration statement on Wednesday seeking to raise capital to develop its pipeline of respiratory disease treatments. The post StockWatch: IPO Market Shows Sign of Life with Avalyn Filing appeared first on GEN - Genetic Engineering and Biotechnology News .